Build a Manufacturing Relationship That Supports Growth

Choosing the right skincare manufacturing partner requires more than comparing unit prices or reviewing a product catalog. Established brands need a partner that can protect product quality, manage complex production, support regulatory responsibilities, and scale with demand. The decision can affect formulation, supply continuity, packaging performance, inventory, and future launches.

Bayport Laboratories supports enterprise beauty brands with manufacturing services aligned with their commercial goals, quality standards, and production volumes. A thorough evaluation should cover the manufacturing model, technical expertise, quality systems, testing, capacity, sourcing, packaging, commercial terms, and long-term governance.

Enterprise skincare manufacturing partner evaluation

Start With the Right Manufacturing Model

First, determine whether the project requires custom formulation, private label, or turnkey support. Each model creates different expectations for differentiation, ownership, timing, and cost.

Manufacturing Model	Best Suited For	What to Confirm
Custom formulation	Proprietary products built around defined performance, ingredients, texture, claims, and packaging	Development process, formula ownership, testing, pilot batches, and scale-up
Private label	Faster launches based on an existing formula	Permitted customization, exclusivity, documentation, and whether changes require new testing
Turnkey manufacturing	Brands seeking coordinated formulation, sourcing, filling, packaging, and assembly	Which services are performed in-house, which are outsourced, and who owns each approval

An existing formula may shorten development, but it does not eliminate qualification or testing. A fully custom program may provide stronger differentiation but require more development time and technical review.

Evaluate Formulation and Technical Capabilities

A manufacturer’s expertise should support both current products and future category expansion. Experience with basic emulsions does not necessarily demonstrate capability in complex formulas or specialized packaging.

Evaluate the manufacturer’s experience with:

Product feasibility and development
Raw-material sourcing
Sampling and formulation revisions
Stability and packaging compatibility
Pilot batches and commercial scale-up
Specifications and manufacturing instructions

Technology transfer may also require material-equivalency reviews, process adjustments, pilot production, updated specifications, and confirmation testing.

Review the manufacturer’s cosmetic manufacturing capabilities and confirm that its experience, equipment, and filling formats match the proposed formula, packaging, and production volume.

Examine Quality Systems and Regulatory Readiness

Certifications can provide useful evidence, but they should not replace an operational quality system review. Confirm the standard, certification body, facility address, audit scope, status, expiration date, and any exclusions.

ISO 22716 provides guidelines for Good Manufacturing Practice in cosmetics for production, control, storage, and shipment. In the United States, the FDA’s draft cosmetic GMP guidance remains draft guidance and should not be described as a final cosmetic GMP regulation.

Review whether the manufacturer actively controls:

Supplier and incoming material qualification
Equipment calibration and maintenance
Cleaning, sanitation, and line clearance
Master manufacturing instructions and batch records
Finished-product testing and release
Deviations, corrective actions, and change control
Complaints, recalls, training, and document retention

Under the Modernization of Cosmetics Regulation Act of 2022, applicable facilities must register, and responsible persons must list marketed cosmetic products. However, the FDA explains that facility registration and product listing are not cosmetic approval programs. Registration should therefore be verified separately from quality-system performance.

Review Testing and Product-Specific Controls

Testing should reflect the product’s:

Formula
Packaging
Intended use
Claims
Target markets
Proposed shelf life

Avoid treating one standard testing package as sufficient for every skincare product.

Evaluate the Testing Program

Confirm the manufacturer’s approach to:

Accelerated and real-time stability testing
Microbiological limits
Challenge testing when appropriate
Packaging compatibility and functionality
Physical and chemical specifications
Product-performance testing
Out-of-specification investigations
Retained samples

Brands should also ask:

Who establishes protocols and acceptance criteria?
Which tests occur in-house?
Which tests are outsourced?
Will the brand receive complete reports?
How are unexpected results investigated?

Quality control can confirm that a batch meets approved specifications. It should not be presented as proof that a product is safe or effective under every use condition.

Address Product-Specific Risks

Testing requirements vary by formula and packaging format.

For example:

Water-based products may require different microbiological controls from anhydrous formulas.
Pumps and droppers may require compatibility, leakage, and dose-delivery testing.
Jars may introduce different contamination and compatibility considerations.
Sprays may require spray-pattern, output, and clogging tests.

The testing program should reflect the actual product rather than rely on a generic checklist.

Confirm Capacity, Supply, and Packaging Readiness

The right manufacturing partner should support projected demand, not only the first production run.

Verify Production Capacity

Evaluate the facility’s:

Available batch sizes
Mixing equipment
Filling lines and formats
Labor and scheduling capacity
Warehousing
Final assembly capabilities

Ask the manufacturer:

What batch sizes and filling formats can the facility handle?
How much capacity is available on the required equipment?
When are forecasts and purchase orders due?
How is capacity reserved during peak periods?
What continuity plans address equipment, utility, or supplier disruptions?

Review Supply-Chain Controls

Confirm how the manufacturer manages:

Qualified suppliers
Certificates of Analysis
Material specifications
Lot-level traceability
Ingredient and component lead times
Approved alternatives
Shortages and discontinuities
Change notifications

Alternate materials should receive appropriate technical, quality, regulatory, stability, and compatibility reviews before use.

Evaluate Packaging Readiness

Packaging should be treated as part of the finished product. Whenever possible, compatibility testing should use the intended formula and final component system.

Clearly assign responsibility for:

Component specifications
Incoming inspections
Defect tolerances
Compatibility and functional testing
Filling-line trials
Label placement
Packaging validation
Retesting after material or design changes

Compare Total Cost, MOQs, and Lead Times

Unit price does not reflect the full commercial impact of a manufacturing relationship. Evaluate total cost, order requirements, inventory exposure, and scheduling before selecting a partner.

Calculate the Total Program Cost

The commercial review should include:

Formulation and sampling fees
Pilot and scale-up charges
Raw materials and production overages
Testing and retesting
Packaging, decoration, and tooling
Setup and changeover charges
Filling, labeling, and assembly
Freight and storage
Payment terms and price adjustments
Responsibility for excess or obsolete inventory

Ask which costs are included in the quoted unit price and which are billed separately.

Evaluate Minimum Order Quantities

MOQs may depend on:

Formula requirements
Equipment and batch capacity
Raw-material commitments
Packaging minimums
Decoration methods
Product variants
Production complexity

Compare the manufacturer’s normal production scale with realistic forecasts. Avoid relying on a universal industry MOQ.

Break Down the Lead Time

Request separate timelines for:

Formula development
Testing and approval
Ingredient sourcing
Packaging procurement
Production scheduling
Manufacturing and filling
Quality release
Shipping

This breakdown makes dependencies, approvals, and potential delays easier to manage.

Clarify Ownership, Responsibilities, and Communication

Before development or technology transfer begins, document who owns the formula, data, decisions, and deliverables.

Define Ownership and Access Rights

Written agreements should address:

Ownership of new and modified formulas
Access to quantitative formulas and procedures
Ownership and use of specifications and testing data
Exclusivity and formula-buyout terms
Confidentiality and data security
Record access and retention
Formula-transfer rights
Exit responsibilities

Confirm Access to the Complete Formula

An ingredient list is not a complete manufacturing formula.

Reproducible manufacturing may require:

Exact ingredient percentages
Raw-material trade names
Processing order
Addition temperatures
Mixing speeds and times
Equipment requirements
In-process controls

Confirm that the agreement provides access to the information needed if production transfers to another qualified facility.

Establish Clear Governance

Assign ownership for:

Commercial decisions
Technical and formulation matters
Quality and regulatory issues
Packaging and sourcing
Forecasts and production priorities
Changes and deviations
Delays and escalations

A quality agreement can also define responsibility for specifications, testing, batch release, complaints, recalls, audits, records, and regulatory communication.

The manufacturing relationship should have documented communication channels and should not depend on a single sales contact.

Use an Enterprise Evaluation Scorecard

A weighted scorecard helps stakeholders compare manufacturers using consistent evidence.

Evaluation Area	Suggested Weight	Evidence to Review
Quality and regulatory readiness	25%	Procedures, audits, certifications, release controls
Technical expertise and testing	20%	Laboratory capabilities, pilots, scale-up, reports
Capacity and continuity	15%	Equipment, availability, forecasts, contingency plans
Supply chain and packaging	15%	Traceability, alternates, compatibility, line trials
Commercial terms	10%	Total cost, MOQs, lead times, payment terms
IP and transfer rights	10%	Ownership, access, confidentiality, exit provisions
Communication and governance	5%	Reporting, approvals, escalation, service expectations

Score only what the manufacturer can support with current evidence. Company history and a polished proposal should not substitute for relevant records and demonstrated facility capabilities.

Questions to Ask a Potential Skincare Manufacturing Partner

Use these questions during early qualification:

Which formulas, categories, and packaging formats does the facility routinely handle?
Which quality standards, registrations, and certifications apply to this location?
Which tests are recommended, and which services are outsourced?
How are suppliers, substitutions, deviations, and changes controlled?
What capacity and MOQs apply to each formula and packaging configuration?
Who owns the formula, specifications, and testing data?
How are delays, risks, and quality concerns escalated?
What support is provided if production transfers to another facility?

Frequently Asked Questions

Should an enterprise brand audit the manufacturing facility?

An on-site or risk-based audit can help determine whether documented procedures match daily operations. Review material flow, sanitation, equipment status, laboratory practices, batch records, warehousing, training, traceability, and change controls.

How should a brand compare custom formulation with private label?

Compare differentiation, ownership, permitted customization, documentation, testing, exclusivity, scalability, launch timing, and transfer rights. The right model is the one that supports the brand’s commercial strategy rather than simply offering the lowest initial cost.

What warning signs may appear during qualification?

Warning signs include unverifiable certifications, unclear testing responsibilities, resistance to audits, undocumented substitutions, unrealistic timelines, weak traceability, incomplete formula-ownership terms, and inconsistent answers across departments.

How often should manufacturer performance be reviewed?

Use a risk-based schedule informed by audit findings, complaints, deviations, delivery performance, regulatory changes, supplier changes, and new product categories. Significant quality or operational changes may justify an earlier review.

Choose a Partner Built for Long-Term Skincare Growth

The right skincare manufacturing partner should combine technical expertise, disciplined quality systems, reliable sourcing, scalable production, transparent commercial terms, and clear communication. Evaluating these capabilities with documented evidence helps established brands protect product quality while planning future growth.

Bayport Laboratories provides formulation, filling, packaging coordination, and commercial-scale production across skincare and other beauty categories.

Contact our team to discuss your current portfolio and future launches.

References

International Organization for Standardization. (2007). ISO 22716:2007 Cosmetics: Good Manufacturing Practices (GMP): Guidelines on Good Manufacturing Practices. https://www.iso.org/standard/36437.html

U.S. Food and Drug Administration. (2013, June). Draft Guidance for Industry: Cosmetic Good Manufacturing Practices. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/draft-guidance-industry-cosmetic-good-manufacturing-practices

U.S. Food and Drug Administration. (n.d.). Modernization of Cosmetics Regulation Act of 2022 (MoCRA). https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022-mocra

U.S. Food and Drug Administration. (2026). Registration and Listing of Cosmetic Product Facilities and Products. https://www.fda.gov/cosmetics/registration-listing-cosmetic-product-facilities-and-products

How Enterprise Brands Choose a Skincare Manufacturing Partner